Inventor
REUTLINGER MICHAEL
CH17 patents
Patents
17 patentsUS10730881B2Aug 4, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE2 citations73
US10428108B2Oct 1, 2019
Difluoroketamide derivatives
HOFFMANN LA ROCHE5 citations72
US9980929B2May 29, 2018
Trifluoromethylpropanamide derivatives
HOFFMANN LA ROCHE5 citations72
US10941147B2Mar 9, 2021
Bicyclic heteroaryl derivatives
HOFFMANN LA ROCHE5 citations70
US11319314B2May 3, 2022
Phenoxytriazoles
HOFFMANN LA ROCHE1 citations62
US10899766B2Jan 26, 2021
Bridged piperidine derivatives
HOFFMANN LA ROCHE1 citations60
US11440915B2Sep 13, 2022
Triazolo-azepine derivatives
HOFFMANN LA ROCHE1 citations58
US11414420B2Aug 16, 2022
Pyrimidine derivatives
HOFFMANN LA ROCHE0 citations58
US11739095B2Aug 29, 2023
Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulators
HOFFMANN LA ROCHE2 citations55
US11001555B2May 11, 2021
Difluoroketamide derivatives as HTRA1 inhibitors
HOFFMANN LA ROCHE0 citations52
US11059858B2Jul 13, 2021
Difluoroketamide derivatives as HtrA1 inhibitors
HOFFMANN LA ROCHE0 citations51
US11014963B2May 25, 2021
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
HOFFMANN LA ROCHE0 citations51
US12528784B2Jan 20, 2026
Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors
HOFFMANN LA ROCHE0 citations43
US10870623B2Dec 22, 2020
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
HOFFMANN LA ROCHE0 citations41
US10865182B2Dec 15, 2020
Difluoroketamide derivatives as HtrA1 inhibitors
HOFFMANN LA ROCHE0 citations41
US10669276B2Jun 2, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE0 citations41
US10647721B2May 12, 2020
Bicyclic heteroaryl derivatives
HOFFMANN LA ROCHE0 citations40